Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists

Details for Australian Patent Application No. 2001295002 (hide)

International Classifications

Event Publications

26 April 2007 Change of Name(s) of Applicant(s), Section 104

Imclone Systems Incorporated The name of the applicant has been changed to ImClone Systems Incorporated 2002

31 May 2007 Application Accepted

Published as AU-B-2001295002

27 September 2007 Standard Patent Sealed

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.